Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Kidney Failure Chronic
- Renal Insufficiency
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 60 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02314403
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Tatsuo Kawai, MD PhD Massachusetts General Hospital
Get Well Soon